Tirzepatide 30 mg Vial

A dual GIP/GLP‑1 receptor agonist, Tirzepatide 30 mg is supplied as a lyophilized powder for reconstitution and once‑weekly subcutaneous injection. It enhances insulin sensitivity, delays gastric emptying, and suppresses appetite to support significant weight loss and blood‑sugar control. Store refrigerated and administer under medical supervision.